Literature DB >> 24948490

Echocardiographic determinants of peak aerobic capacity and breathing efficiency in patients with undifferentiated dyspnea.

Jeremy J Thaden1, Robert B McCully2, Stephen L Kopecky2, Thomas G Allison2.   

Abstract

Diastolic function and E/e' correlate with peak aerobic capacity (VO2) in patients with heart failure, but the echocardiographic correlates of abnormal gas exchange in patients without heart failure are not well defined. We sought to determine the echocardiographic correlates of peak VO2 and breathing efficiency (estimated using the ratio of minute ventilation to carbon dioxide production, or VE/VCO2 nadir) in patients with unexplained dyspnea. We identified 232 patients with unexplained dyspnea who underwent echocardiography at rest followed by stress echocardiography with simultaneous measurement of peak VO2 and VE/VCO2 nadir. At baseline, 17 patients (5%) had an E/e' of ≥15 while 31 patients (17%) had a right ventricular systolic pressure (RVSP) of >35 mm Hg. E/e' ≥15 and RVSP >35 mm Hg were associated with lower peak VO2 (14.1 ± 4.4 vs 21.0 ± 6.9 and 15.2 ± 3.6 vs 21.8 ± 6.8 ml/kg/min, respectively, p <0.0001). E/e' ≥15 (sensitivity 0.13, specificity 0.99, area under the curve 0.64) and RVSP >35 mm Hg (sensitivity 0.38, specificity 0.93, area under the curve 0.76) were highly specific for predicting limited peak VO2. Age and RVSP at rest were independent correlates with VE/VCO2, but diastolic function was not. However, the risk of having abnormal VE/VCO2 nadir was only elevated in subjects with elevated RVSP in the setting of abnormal diastolic function (hazard ratio 2.4, 95% confidence interval 1.3 to 4.6, p = 0.02). In conclusion, both E/e' ≥15 and RVSP >35 mm Hg are highly specific markers of exercise limitation in patients without heart failure, but RVSP at rest may offer better overall diagnostic power than E/e' to predict low peak VO2 in this group.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24948490     DOI: 10.1016/j.amjcard.2014.04.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Diastolic dysfunction and exercise capacity in patients with metabolic syndrome and overweight/obesity.

Authors:  Angel M Alonso-Gómez; Lucas Tojal Sierra; Elena Fortuny Frau; Leire Goicolea Güemez; Ane Aboitiz Uribarri; María P Portillo; Estefanía Toledo; Helmut Schröder; Jordi Salas-Salvadó; Fernando Arós Borau
Journal:  Int J Cardiol Heart Vasc       Date:  2018-12-27

2.  Combined use of stress echocardiography and cardiopulmonary exercise testing to assess exercise intolerance in patients treated for acute myocardial infarction.

Authors:  Krzysztof Smarz; Tomasz Jaxa-Chamiec; Beata Zaborska; Maciej Tysarowski; Andrzej Budaj
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.